News coverage about Orthopediatrics (NASDAQ:KIDS) has been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Orthopediatrics earned a news impact score of 0.02 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.8413155128458 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the headlines that may have effected Accern Sentiment’s analysis:
Orthopediatrics (NASDAQ:KIDS) traded down $0.30 during trading hours on Thursday, hitting $19.09. The stock had a trading volume of 42,000 shares, compared to its average volume of 54,357. The company has a market cap of $244.60 and a price-to-earnings ratio of 19.89. Orthopediatrics has a 1-year low of $17.03 and a 1-year high of $23.00. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00.
KIDS has been the subject of a number of research reports. Stifel Nicolaus initiated coverage on Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $23.00 price target for the company. BTIG Research reissued a “buy” rating and set a $24.00 price target on shares of Orthopediatrics in a research note on Friday, January 5th. William Blair initiated coverage on Orthopediatrics in a research note on Monday, November 6th. They set an “outperform” rating for the company. BidaskClub lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday. Finally, Piper Jaffray Companies initiated coverage on Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 price target for the company. Two equities research analysts have rated the stock with a sell rating and four have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $23.67.
In related news, Director Harold Ruf acquired 11,500 shares of the stock in a transaction dated Monday, October 16th. The stock was acquired at an average cost of $13.00 per share, with a total value of $149,500.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Orthopediatrics (KIDS) Stock Price” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/01/11/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-orthopediatrics-kids-stock-price.html.
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.